Original document(15 pages)  中文版
    This invention involves NGAL protein, and disclosed the recombinant Pichia pastoris and methods of expression of NGAL with Pichia pastoris. High expression of recombinant Pichia pastoris strains were obtained through PCR amplification, ligation, transformation and screening. The strain can excrete target protein into the medium and the protein concentration can reach to more than 100 mg / L, but no contaminant proteins. This makes the purification process becomes very simple: the broth was precipitated by ammonium sulfate, desalted, and separated by cation exchange chromatography. The products are superior to protein derived from prokaryotes, The glycosylation is integrate, and it is available for functional studies and clinical testing standards of NGAL protein.
Application Number
申请号
200610123677 Application Date
申请日
2006.11.21
Title 名称 Recombinant yeast pichia pastoris and its method for expressing NGAL protein
Publication Number
公开号
1978632 Publication Date
公开日
2007.06.13
Approval Pub. Date Granted Pub. Date
International Classification 分类号 C12N1/19;C12N15/12;C07K14/435;C12R1/84
Applicant(s) Name
申请人
Medical School, Shantou Univ.
Address 地址
Inventor(s) Name 发明人 Li Enmin;Zhang Pixian;Wu Bingli;Du Zepeng;Xu Liyan
Attorney & Agent 代理人 chenwei
More information 更  多  信  息


 Related patents information
Ezrin gene promoter for human esophagus cancer cell
Application of siRNA inhibiting human Ezrin gene expression in esophagus cancer cell traveling invasion research
siRNA for inhibiting human Ezrin gene expression and expression carrier thereof
Application of siRNA suppressing human Ezrin gene expression in the research on esophagus carcinoma proliferation
Upstream transcription control element for human oesophagus cancer cell ezrin gene
Transcriptional control element of human lung carcinoma cell NGAL gene promoter region
Controlling element for human esophagus cancer cell Fascin gene promoter region
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.